To clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers, and for other purposes.
The bill’s titles are written by its sponsor.
Oct 1, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on October 1, 2015, in a previous session of Congress, but was not enacted.
Representative for Pennsylvania's 3rd congressional district
Read Text »
Last Updated: Oct 1, 2015
Length: 4 pages
Oct 1, 2015
H.R. 3678 (114th) was a bill in the United States Congress.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2017). H.R. 3678 — 114th Congress: Preserving Access to Orphan Drugs Act of 2015. Retrieved from https://www.govtrack.us/congress/bills/114/hr3678
“H.R. 3678 — 114th Congress: Preserving Access to Orphan Drugs Act of 2015.” www.GovTrack.us. 2015. September 25, 2017 <https://www.govtrack.us/congress/bills/114/hr3678>
|title=H.R. 3678 (114th)
|accessdate=September 25, 2017
|author=114th Congress (2015)
|date=October 1, 2015
|quote=Preserving Access to Orphan Drugs Act of 2015